4th Quarter - Report
CAPITOL HILL CONSULTING GROUP for ENDO PHARMACEUTICALS
Client
Income
$45,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; research and development; life sciences research tax credit legislation; H.R. 2632/S. 1410; the Life Sciences Jobs and Investment Act of 2011, biosimiliars; prescription and generic drug user fees legislation; H.R. 6160, Stop Tampering of Prescription Pills Act of 2012.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| DAVID JORY | — |
| AMY SHANK | 2001-2002 Ofc. of Asst. GOP Leader Don Nickles |
Medicare/Medicaid MMM
General Medicare and Medicaid issues, including, but not limited to, coverage and reimbursement
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER | — |
| DAVID JORY | — |
| AMY SHANK | 2001-2002 Ofc. of Asst. GOP Leader Don Nickles |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.